APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccine (Include COVID-19)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vaccine (Include COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174044840321 December 2025193 pages

Choose your research edition.

Industry ResearchVaccine (Include COVID-19) Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine (Include COVID-19) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Vaccine (Include COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine (Include COVID-19) Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine (Include COVID-19) Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Vaccine (Include COVID-19) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine (Include COVID-19) include Sanofi, Merck, Pfizer, GSK, AstraZeneca, Zhejiang Pukang, Walvax Biotechnology, Viatris and Sinovac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Vaccine (Include COVID-19) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine (Include COVID-19) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine (Include COVID-19) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Vaccine (Include COVID-19) market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine (Include COVID-19) Segment by Company

Sanofi

Merck

Pfizer

GSK

AstraZeneca

Zhejiang Pukang

Walvax Biotechnology

Viatris

Sinovac

Sinovac

Serum Institute

Panacea Biotec Ltd

LG Life Sciences

KM Biologics

Hualan Bio

Halfkin Bio-Pharmaceuticals

CSL

Changchun Institute of Biological

Bio-Med

Bharat Biotech

Vaccine (Include COVID-19) Segment by Type

Inactivated Vaccine

Attenuated Vaccine

mRNA

Other

Vaccine (Include COVID-19) Segment by Application

Public

Private

Vaccine (Include COVID-19) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine (Include COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine (Include COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine (Include COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vaccine (Include COVID-19) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine (Include COVID-19) industry.

Chapter 3: Detailed analysis of Vaccine (Include COVID-19) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine (Include COVID-19)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine (Include COVID-19) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Inactivated Vaccine Table 3. Key Players of Attenuated Vaccine Table 4. Key Players of mRNA Table 3. Key Players of Other Table 4. Global Vaccine (Include COVID-19) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Public Table 6. Key Players of Private Table 7. Global Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Vaccine (Include COVID-19) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Vaccine (Include COVID-19) Market Share by Region (2021-2026) Table 10. Global Vaccine (Include COVID-19) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Vaccine (Include COVID-19) Market Share by Region (2027-2032) Table 12. Vaccine (Include COVID-19) Industry Trends Table 13. Vaccine (Include COVID-19) Industry Drivers Table 14. Vaccine (Include COVID-19) Industry Opportunities and Challenges Table 15. Vaccine (Include COVID-19) Industry Restraints Table 16. Global Vaccine (Include COVID-19) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Vaccine (Include COVID-19) Revenue Market Share by Company (2021-2026) Table 18. Global Vaccine (Include COVID-19) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Vaccine (Include COVID-19) Key Company Head Office and Area Served Table 20. Global Vaccine (Include COVID-19) Company, Product Type & Application Table 21. Global Vaccine (Include COVID-19) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Vaccine (Include COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Vaccine (Include COVID-19) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Vaccine (Include COVID-19) Revenue Market Share by Type (2021-2026) Table 28. Global Vaccine (Include COVID-19) Revenue Market Share by Type (2027-2032) Table 29. Global Vaccine (Include COVID-19) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Vaccine (Include COVID-19) Revenue Market Share by Application (2021-2026) Table 33. Global Vaccine (Include COVID-19) Revenue Market Share by Application (2027-2032) Table 34. Sanofi Company Information Table 35. Sanofi Business Overview Table 36. Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Sanofi Vaccine (Include COVID-19) Product Portfolio Table 38. Sanofi Recent Development Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Merck Vaccine (Include COVID-19) Product Portfolio Table 43. Merck Recent Development Table 44. Pfizer Company Information Table 45. Pfizer Business Overview Table 46. Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Pfizer Vaccine (Include COVID-19) Product Portfolio Table 48. Pfizer Recent Development Table 49. GSK Company Information Table 50. GSK Business Overview Table 51. GSK Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. GSK Vaccine (Include COVID-19) Product Portfolio Table 53. GSK Recent Development Table 54. AstraZeneca Company Information Table 55. AstraZeneca Business Overview Table 56. AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AstraZeneca Vaccine (Include COVID-19) Product Portfolio Table 58. AstraZeneca Recent Development Table 59. Zhejiang Pukang Company Information Table 60. Zhejiang Pukang Business Overview Table 61. Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Zhejiang Pukang Vaccine (Include COVID-19) Product Portfolio Table 63. Zhejiang Pukang Recent Development Table 64. Walvax Biotechnology Company Information Table 65. Walvax Biotechnology Business Overview Table 66. Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Walvax Biotechnology Vaccine (Include COVID-19) Product Portfolio Table 68. Walvax Biotechnology Recent Development Table 69. Viatris Company Information Table 70. Viatris Business Overview Table 71. Viatris Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Viatris Vaccine (Include COVID-19) Product Portfolio Table 73. Viatris Recent Development Table 74. Sinovac Company Information Table 75. Sinovac Business Overview Table 76. Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Sinovac Vaccine (Include COVID-19) Product Portfolio Table 78. Sinovac Recent Development Table 79. Sinovac Company Information Table 80. Sinovac Business Overview Table 81. Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Sinovac Vaccine (Include COVID-19) Product Portfolio Table 83. Sinovac Recent Development Table 84. Serum Institute Company Information Table 85. Serum Institute Business Overview Table 86. Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Serum Institute Vaccine (Include COVID-19) Product Portfolio Table 88. Serum Institute Recent Development Table 89. Panacea Biotec Ltd Company Information Table 90. Panacea Biotec Ltd Business Overview Table 91. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Portfolio Table 93. Panacea Biotec Ltd Recent Development Table 94. LG Life Sciences Company Information Table 95. LG Life Sciences Business Overview Table 96. LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. LG Life Sciences Vaccine (Include COVID-19) Product Portfolio Table 98. LG Life Sciences Recent Development Table 99. KM Biologics Company Information Table 100. KM Biologics Business Overview Table 101. KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. KM Biologics Vaccine (Include COVID-19) Product Portfolio Table 103. KM Biologics Recent Development Table 104. Hualan Bio Company Information Table 105. Hualan Bio Business Overview Table 106. Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Hualan Bio Vaccine (Include COVID-19) Product Portfolio Table 108. Hualan Bio Recent Development Table 109. Halfkin Bio-Pharmaceuticals Company Information Table 110. Halfkin Bio-Pharmaceuticals Business Overview Table 111. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Portfolio Table 113. Halfkin Bio-Pharmaceuticals Recent Development Table 114. CSL Company Information Table 115. CSL Business Overview Table 116. CSL Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. CSL Vaccine (Include COVID-19) Product Portfolio Table 118. CSL Recent Development Table 119. Changchun Institute of Biological Company Information Table 120. Changchun Institute of Biological Business Overview Table 121. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Changchun Institute of Biological Vaccine (Include COVID-19) Product Portfolio Table 123. Changchun Institute of Biological Recent Development Table 124. Bio-Med Company Information Table 125. Bio-Med Business Overview Table 126. Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Bio-Med Vaccine (Include COVID-19) Product Portfolio Table 128. Bio-Med Recent Development Table 129. Bharat Biotech Company Information Table 130. Bharat Biotech Business Overview Table 131. Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Bharat Biotech Vaccine (Include COVID-19) Product Portfolio Table 133. Bharat Biotech Recent Development Table 134. North America Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 135. North America Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 136. North America Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 137. North America Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 138. North America Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Vaccine (Include COVID-19) Market Size by Country (2021-2026) Table 140. North America Vaccine (Include COVID-19) Market Size by Country (2027-2032) Table 141. Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 142. Europe Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 143. Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 144. Europe Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 145. Europe Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026) Table 147. Europe Vaccine (Include COVID-19) Market Size by Country (2027-2032) Table 148. China Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 149. China Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 150. China Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 151. China Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 153. Asia Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 154. Asia Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 155. Asia Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 156. Asia Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Vaccine (Include COVID-19) Market Size by Country (2021-2026) Table 158. Asia Vaccine (Include COVID-19) Market Size by Country (2027-2032) Table 159. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 160. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2027-2032) & (US$ Million) Table 161. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 162. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2027-2032) & (US$ Million) Table 163. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021-2026) Table 165. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2027-2032) Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Vaccine (Include COVID-19) Product Image Figure 2. Global Vaccine (Include COVID-19) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Vaccine (Include COVID-19) Market Share by Type: 2025 VS 2032 Figure 4. Inactivated Vaccine Image Figure 5. Attenuated Vaccine Image Figure 6. mRNA Image Figure 7. Other Image Figure 8. Global Vaccine (Include COVID-19) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Vaccine (Include COVID-19) Market Share by Application: 2025 VS 2032 Figure 10. Public Image Figure 11. Private Image Figure 12. Global Vaccine (Include COVID-19) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 14. Global Vaccine (Include COVID-19) Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Vaccine (Include COVID-19) Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Vaccine (Include COVID-19) Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Vaccine (Include COVID-19) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Vaccine (Include COVID-19) Revenue Market Share by Type (2021-2032) Figure 21. Global Vaccine (Include COVID-19) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Vaccine (Include COVID-19) Revenue Market Share by Application (2021-2032) Figure 23. North America Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 24. North America Vaccine (Include COVID-19) Market Share by Type (2021-2032) Figure 25. North America Vaccine (Include COVID-19) Market Share by Application (2021-2032) Figure 26. North America Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 27. United States Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 28. Canada Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 30. Europe Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 31. Europe Vaccine (Include COVID-19) Market Share by Type (2021-2032) Figure 32. Europe Vaccine (Include COVID-19) Market Share by Application (2021-2032) Figure 33. Europe Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 34. Germany Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 35. France Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 37. Italy Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 38. Russia Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 40. China Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 41. China Vaccine (Include COVID-19) Market Share by Type (2021-2032) Figure 42. China Vaccine (Include COVID-19) Market Share by Application (2021-2032) Figure 43. Asia Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 44. Asia Vaccine (Include COVID-19) Market Share by Type (2021-2032) Figure 45. Asia Vaccine (Include COVID-19) Market Share by Application (2021-2032) Figure 46. Asia Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 47. Japan Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 51. India Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 52. Australia Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 57. Brazil Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 62. UAE Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 64. Chile Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
  • mRNA
  • Other
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • GSK
  • AstraZeneca
  • Zhejiang Pukang
  • Walvax Biotechnology
  • Viatris
  • Sinovac
  • Sinovac
  • Serum Institute
  • Panacea Biotec Ltd
  • LG Life Sciences
  • KM Biologics
  • Hualan Bio
  • Halfkin Bio-Pharmaceuticals
  • CSL
  • Changchun Institute of Biological
  • Bio-Med
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Vaccine (Include COVID-19) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Vaccine
  5. 1.2.3 Attenuated Vaccine
  6. 1.2.4 mRNA
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Vaccine (Include COVID-19) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Public
  11. 1.3.3 Private
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Vaccine (Include COVID-19) Growth Trends by Region
  14. 1.5.1 Global Vaccine (Include COVID-19) Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Vaccine (Include COVID-19) Market Size by Region (2021-2026)
  16. 1.5.3 Vaccine (Include COVID-19) Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Vaccine (Include COVID-19) Market Dynamics
  1. 2.1 Vaccine (Include COVID-19) Industry Trends
  2. 2.2 Vaccine (Include COVID-19) Industry Drivers
  3. 2.3 Vaccine (Include COVID-19) Industry Opportunities and Challenges
  4. 2.4 Vaccine (Include COVID-19) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Vaccine (Include COVID-19) Revenue by Company (2021-2026)
  2. 3.2 Global Vaccine (Include COVID-19) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Vaccine (Include COVID-19) Key Company Head office and Area Served
  4. 3.4 Global Vaccine (Include COVID-19) Company, Product Type & Application
  5. 3.5 Global Vaccine (Include COVID-19) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Vaccine (Include COVID-19) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Vaccine (Include COVID-19) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Vaccine (Include COVID-19) Tier 1, Tier 2, and Tier 3
4 Vaccine (Include COVID-19) Market by Type
  1. 4.1 Global Vaccine (Include COVID-19) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Vaccine (Include COVID-19) Market Size by Type (2021-2032)
  3. 4.3 Global Vaccine (Include COVID-19) Market Size Share by Type (2021-2032)
5 Vaccine (Include COVID-19) Market by Application
  1. 5.1 Global Vaccine (Include COVID-19) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Vaccine (Include COVID-19) Market Size by Application (2021-2032)
  3. 5.3 Global Vaccine (Include COVID-19) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Vaccine (Include COVID-19) Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Vaccine (Include COVID-19) Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Vaccine (Include COVID-19) Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GSK Vaccine (Include COVID-19) Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Vaccine (Include COVID-19) Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Zhejiang Pukang
  32. 6.6.1 Zhejiang Pukang Company Information
  33. 6.6.2 Zhejiang Pukang Business Overview
  34. 6.6.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Zhejiang Pukang Vaccine (Include COVID-19) Product Portfolio
  36. 6.6.5 Zhejiang Pukang Recent Developments
  37. 6.7 Walvax Biotechnology
  38. 6.7.1 Walvax Biotechnology Company Information
  39. 6.7.2 Walvax Biotechnology Business Overview
  40. 6.7.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Walvax Biotechnology Vaccine (Include COVID-19) Product Portfolio
  42. 6.7.5 Walvax Biotechnology Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viatris Vaccine (Include COVID-19) Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Sinovac
  50. 6.9.1 Sinovac Company Information
  51. 6.9.2 Sinovac Business Overview
  52. 6.9.3 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sinovac Vaccine (Include COVID-19) Product Portfolio
  54. 6.9.5 Sinovac Recent Developments
  55. 6.10 Sinovac
  56. 6.10.1 Sinovac Company Information
  57. 6.10.2 Sinovac Business Overview
  58. 6.10.3 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sinovac Vaccine (Include COVID-19) Product Portfolio
  60. 6.10.5 Sinovac Recent Developments
  61. 6.11 Serum Institute
  62. 6.11.1 Serum Institute Company Information
  63. 6.11.2 Serum Institute Business Overview
  64. 6.11.3 Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Serum Institute Vaccine (Include COVID-19) Product Portfolio
  66. 6.11.5 Serum Institute Recent Developments
  67. 6.12 Panacea Biotec Ltd
  68. 6.12.1 Panacea Biotec Ltd Company Information
  69. 6.12.2 Panacea Biotec Ltd Business Overview
  70. 6.12.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Portfolio
  72. 6.12.5 Panacea Biotec Ltd Recent Developments
  73. 6.13 LG Life Sciences
  74. 6.13.1 LG Life Sciences Company Information
  75. 6.13.2 LG Life Sciences Business Overview
  76. 6.13.3 LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 LG Life Sciences Vaccine (Include COVID-19) Product Portfolio
  78. 6.13.5 LG Life Sciences Recent Developments
  79. 6.14 KM Biologics
  80. 6.14.1 KM Biologics Company Information
  81. 6.14.2 KM Biologics Business Overview
  82. 6.14.3 KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 KM Biologics Vaccine (Include COVID-19) Product Portfolio
  84. 6.14.5 KM Biologics Recent Developments
  85. 6.15 Hualan Bio
  86. 6.15.1 Hualan Bio Company Information
  87. 6.15.2 Hualan Bio Business Overview
  88. 6.15.3 Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Hualan Bio Vaccine (Include COVID-19) Product Portfolio
  90. 6.15.5 Hualan Bio Recent Developments
  91. 6.16 Halfkin Bio-Pharmaceuticals
  92. 6.16.1 Halfkin Bio-Pharmaceuticals Company Information
  93. 6.16.2 Halfkin Bio-Pharmaceuticals Business Overview
  94. 6.16.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Portfolio
  96. 6.16.5 Halfkin Bio-Pharmaceuticals Recent Developments
  97. 6.17 CSL
  98. 6.17.1 CSL Company Information
  99. 6.17.2 CSL Business Overview
  100. 6.17.3 CSL Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 CSL Vaccine (Include COVID-19) Product Portfolio
  102. 6.17.5 CSL Recent Developments
  103. 6.18 Changchun Institute of Biological
  104. 6.18.1 Changchun Institute of Biological Company Information
  105. 6.18.2 Changchun Institute of Biological Business Overview
  106. 6.18.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Changchun Institute of Biological Vaccine (Include COVID-19) Product Portfolio
  108. 6.18.5 Changchun Institute of Biological Recent Developments
  109. 6.19 Bio-Med
  110. 6.19.1 Bio-Med Company Information
  111. 6.19.2 Bio-Med Business Overview
  112. 6.19.3 Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Bio-Med Vaccine (Include COVID-19) Product Portfolio
  114. 6.19.5 Bio-Med Recent Developments
  115. 6.20 Bharat Biotech
  116. 6.20.1 Bharat Biotech Company Information
  117. 6.20.2 Bharat Biotech Business Overview
  118. 6.20.3 Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Bharat Biotech Vaccine (Include COVID-19) Product Portfolio
  120. 6.20.5 Bharat Biotech Recent Developments
7 North America
  1. 7.1 North America Vaccine (Include COVID-19) Market Size (2021-2032)
  2. 7.2 North America Vaccine (Include COVID-19) Market Size by Type
  3. 7.2.1 North America Vaccine (Include COVID-19) Market Size by Type (2021-2026)
  4. 7.2.2 North America Vaccine (Include COVID-19) Market Size by Type (2027-2032)
  5. 7.2.3 North America Vaccine (Include COVID-19) Market Share by Type (2021-2032)
  6. 7.3 North America Vaccine (Include COVID-19) Market Size by Application
  7. 7.3.1 North America Vaccine (Include COVID-19) Market Size by Application (2021-2026)
  8. 7.3.2 North America Vaccine (Include COVID-19) Market Size by Application (2027-2032)
  9. 7.3.3 North America Vaccine (Include COVID-19) Market Share by Application (2021-2032)
  10. 7.4 North America Vaccine (Include COVID-19) Market Size by Country
  11. 7.4.1 North America Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  13. 7.4.3 North America Vaccine (Include COVID-19) Market Size by Country (2027-2032)
  14. 7.4.4 North America Vaccine (Include COVID-19) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Vaccine (Include COVID-19) Market Size (2021-2032)
  2. 8.2 Europe Vaccine (Include COVID-19) Market Size by Type
  3. 8.2.1 Europe Vaccine (Include COVID-19) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Vaccine (Include COVID-19) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Vaccine (Include COVID-19) Market Share by Type (2021-2032)
  6. 8.3 Europe Vaccine (Include COVID-19) Market Size by Application
  7. 8.3.1 Europe Vaccine (Include COVID-19) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Vaccine (Include COVID-19) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Vaccine (Include COVID-19) Market Share by Application (2021-2032)
  10. 8.4 Europe Vaccine (Include COVID-19) Market Size by Country
  11. 8.4.1 Europe Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Vaccine (Include COVID-19) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Vaccine (Include COVID-19) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Vaccine (Include COVID-19) Market Size (2021-2032)
  2. 9.2 China Vaccine (Include COVID-19) Market Size by Type
  3. 9.2.1 China Vaccine (Include COVID-19) Market Size by Type (2021-2026)
  4. 9.2.2 China Vaccine (Include COVID-19) Market Size by Type (2027-2032)
  5. 9.2.3 China Vaccine (Include COVID-19) Market Share by Type (2021-2032)
  6. 9.3 China Vaccine (Include COVID-19) Market Size by Application
  7. 9.3.1 China Vaccine (Include COVID-19) Market Size by Application (2021-2026)
  8. 9.3.2 China Vaccine (Include COVID-19) Market Size by Application (2027-2032)
  9. 9.3.3 China Vaccine (Include COVID-19) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Vaccine (Include COVID-19) Market Size (2021-2032)
  2. 10.2 Asia Vaccine (Include COVID-19) Market Size by Type
  3. 10.2.1 Asia Vaccine (Include COVID-19) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Vaccine (Include COVID-19) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Vaccine (Include COVID-19) Market Share by Type (2021-2032)
  6. 10.3 Asia Vaccine (Include COVID-19) Market Size by Application
  7. 10.3.1 Asia Vaccine (Include COVID-19) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Vaccine (Include COVID-19) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Vaccine (Include COVID-19) Market Share by Application (2021-2032)
  10. 10.4 Asia Vaccine (Include COVID-19) Market Size by Country
  11. 10.4.1 Asia Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Vaccine (Include COVID-19) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Vaccine (Include COVID-19) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Vaccine (Include COVID-19) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst